Genprex to Participate at BIO 2025 International Convention
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its team will be attending and participating at the BIO 2025 International Convention taking place June 16-19, 2025 in Boston, Mass. https://mma.prnewswire.com/media/1798169/Genprex_Logo.jpg In attendance from Genprex's executive leadership […]